US › Healthcare

SeaStar Medical Holding Corporation (ICU)

US · Healthcare · Biotechnology

$3.19-0.16%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$495,000
Revenue YoY
+68.9%
Net profit
$-3.5M
Profit YoY
+6.7%
EPS
$-0.90
EPS estimate
$-0.82
Net margin
-711.3%

EPS came in at -0.90 against a street estimate of -0.82 — a miss of 9.8%.

Key statistics

Market cap
$12.8M
Forward P/E
0.0
P/B
1.71
Book value
$1.83
EPS (TTM)
$-2.38
52-week high
$12.50
52-week low
$2.07
50-day MA
$3.70
200-day MA
$3.54
Beta
-1.04

Analyst view

Analysts rate SeaStar Medical Holding Corporation a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Shareholding

Insiders
12.80%
Institutions
7.66%

Largest institutional holders

FundStake
Geode Capital Management, LLC1.39%
Vanguard Capital Management, LLC0.72%
Jane Street Group LLC0.70%
Vanguard Fiduciary Trust Co0.34%
PNC Financial Services Group Inc0.04%
Tower Research Capital LLC0.03%
BlackRock Inc0.02%
UBS Group AG0.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for SeaStar Medical Holding Corporation — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.